Skip to main content

Advertisement

Log in

The Netherlands Epidemiology of Obesity (NEO) study: study design and data collection

  • NEW STUDY
  • Published:
European Journal of Epidemiology Aims and scope Submit manuscript

Abstract

Obesity is a well-established risk factor for many chronic diseases. Incomplete insight exists in the causal pathways responsible for obesity-related disorders and consequently, in the identification of obese individuals at risk of these disorders. The Netherlands Epidemiology of Obesity (NEO) study is designed for extensive phenotyping to investigate pathways that lead to obesity-related diseases. The NEO study is a population-based, prospective cohort study that includes 6,673 individuals aged 45–65 years, with an oversampling of individuals with overweight or obesity. At baseline, data on demography, lifestyle, and medical history have been collected by questionnaires. In addition, samples of 24-h urine, fasting and postprandial blood plasma and serum, and DNA were collected. Participants underwent an extensive physical examination, including anthropometry, electrocardiography, spirometry, and measurement of the carotid artery intima-media thickness by ultrasonography. In random subsamples of participants, magnetic resonance imaging of abdominal fat, pulse wave velocity of the aorta, heart, and brain, magnetic resonance spectroscopy of the liver, indirect calorimetry, dual-energy X-ray absorptiometry, or accelerometry measurements were performed. The collection of data started in September 2008 and completed at the end of September 2012. Participants are followed for the incidence of obesity-related diseases and mortality. The NEO study investigates pathways that lead to obesity-related diseases. A better understanding of the mechanisms underlying the development of disease in obesity may help to identify individuals who are susceptible to the detrimental metabolic, cardiovascular and other consequences of obesity and has implications for the development of prevention and treatment strategies.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  1. WHO: Obesity and overweight. In: Fact sheet No 311. http://www.who.int/mediacentre/factsheets/fs311/en/ (2012). Accessed 1 Nov 2012.

  2. Nationaal Kompas Volksgezondheid: http://www.nationaalkompas.nl/gezondheidsdeterminanten/persoonsgebonden/lichaamsgewicht/trend/ (2012). Accessed 1 Nov 2012.

  3. International Obesity TaskForce Prevalence Data: http://www.iaso.org/iotf/obesity/ (2010). Accessed 1 Nov 2012.

  4. Visscher TL, Kromhout D, Seidell JC. Long-term and recent time trends in the prevalence of obesity among Dutch men and women. Int J Obes Relat Metab Disord. 2002;26:1218–24.

    Article  PubMed  CAS  Google Scholar 

  5. Gast GC, Frenken FJ, van Leest LA, Wendel-Vos GC, Bemelmans WJ. Intra-national variation in trends in overweight and leisure time physical activities in The Netherlands since 1980: stratification according to sex, age and urbanisation degree. Int J Obes (Lond). 2007;31:515–20.

    Article  CAS  Google Scholar 

  6. Flegal KM, Carroll MD, Ogden CL, Curtin LR. Prevalence and trends in obesity among US adults, 1999–2008. JAMA. 2010;303:235–41.

    Article  PubMed  CAS  Google Scholar 

  7. James WPT, Jackson-Leach R, Mhurchu CN, Kalamara E, Shayeghi M, Rigby NJ, Nishida C, and Rodgers A: Overweight and obesity (high body mass index). In: Ezzati M, Lopez AD Rodgers A Murray CJL, editors. Comparative quantification of health risks: Global and regional burden of disease attributable to selected major risk factors. Geneva: World Health Organization; 2004. pp 497–596.

  8. WHO Technical Report Series 894. Obesity: preventing and managing the global epidemic. Report of a WHO Consultation. Geneva: World Health Organization; 1999.

  9. Vogelzangs N, Kritchevsky SB, Beekman AT, Brenes GA, Newman AB, Satterfield S, Yaffe K, Harris TB, Penninx BW. Obesity and onset of significant depressive symptoms: results from a prospective community-based cohort study of older men and women. J Clin Psychiatry. 2010;71:391–9.

    Article  PubMed  Google Scholar 

  10. Simon GE, Von KM, Saunders K, Miglioretti DL, Crane PK, van BG, Kessler RC. Association between obesity and psychiatric disorders in the US adult population. Arch Gen Psychiatry. 2006;63:824–30.

    Article  PubMed  Google Scholar 

  11. Stewart ST, Cutler DM, Rosen AB. Forecasting the effects of obesity and smoking on U.S. life expectancy. N Engl J Med. 2009;361:2252–60.

    Article  PubMed  CAS  Google Scholar 

  12. http://www.rivm.nl/nldemaat. Accessed 20 March 2013

  13. Verkleij-Hagoort AC, De Vries JH, Stegers MP, Lindemans J, Ursem NT, Steegers-Theunissen RP. Validation of the assessment of folate and vitamin B12 intake in women of reproductive age: the method of triads. Eur J Clin Nutr. 2007;61:610–5.

    PubMed  CAS  Google Scholar 

  14. Wendel-Vos GC, Schuit AJ, Saris WH, Kromhout D. Reproducibility and relative validity of the short questionnaire to assess health-enhancing physical activity. J Clin Epidemiol. 2003;56:1163–9.

    Article  PubMed  Google Scholar 

  15. de Hollander EL, Zwart L, de Vries SI, Wendel-Vos W. The SQUASH was a more valid tool than the OBiN for categorizing adults according to the Dutch physical activity and the combined guideline. J Clin Epidemiol. 2012;65:73–81.

    Article  PubMed  Google Scholar 

  16. Roos EM, Roos HP, Lohmander LS, Ekdahl C, Beynnon BD. Knee injury and osteoarthritis outcome score (KOOS)–development of a self-administered outcome measure. J Orthop Sports Phys Ther. 1998;28:88–96.

    PubMed  CAS  Google Scholar 

  17. de G, I, Favejee MM, Reijman M, Verhaar JA, Terwee CB: The Dutch version of the knee injury and osteoarthritis outcome score: a validation study. Health Qual Life Outcomes 2008;6:16.

  18. Bellamy N, Campbell J, Haraoui B, Gerecz-Simon E, Buchbinder R, Hobby K, MacDermid JC. Clinimetric properties of the AUSCAN osteoarthritis hand index: an evaluation of reliability, validity and responsiveness. Osteoarthritis Cartilage. 2002;10:863–9.

    Article  PubMed  CAS  Google Scholar 

  19. Bellamy N, Campbell J, Haraoui B, Buchbinder R, Hobby K, Roth JH, MacDermid JC. Dimensionality and clinical importance of pain and disability in hand osteoarthritis: development of the Australian/Canadian (AUSCAN) Osteoarthritis Hand Index. Osteoarthritis Cartilage. 2002;10:855–62.

    Article  PubMed  CAS  Google Scholar 

  20. Johns MW. A new method for measuring daytime sleepiness: the Epworth sleepiness scale. Sleep. 1991;14:540–5.

    PubMed  CAS  Google Scholar 

  21. Buysse DJ, Reynolds CF III, Monk TH, Berman SR, Kupfer DJ. The Pittsburgh sleep quality index: a new instrument for psychiatric practice and research. Psychiatry Res. 1989;28:193–213.

    Article  PubMed  CAS  Google Scholar 

  22. Netzer NC, Stoohs RA, Netzer CM, Clark K, Strohl KP. Using the Berlin questionnaire to identify patients at risk for the sleep apnea syndrome. Ann Intern Med. 1999;131:485–91.

    Article  PubMed  CAS  Google Scholar 

  23. Rush AJ, Gullion CM, Basco MR, Jarrett RB, Trivedi MH. The inventory of depressive symptomatology (IDS): psychometric properties. Psychol Med. 1996;26:477–86.

    Article  PubMed  CAS  Google Scholar 

  24. Beck AT, Epstein N, Brown G, Steer RA. An inventory for measuring clinical anxiety: psychometric properties. J Consult Clin Psychol. 1988;56:893–7.

    Article  PubMed  CAS  Google Scholar 

  25. Fydrich T, Dowdall D, Chambless DL: Reliability and validity of the beck anxiety inventory. J Anxiety Disorders 1992;55–61.

  26. Brugha TS, Cragg D. The list of threatening experiences: the reliability and validity of a brief life events questionnaire. Acta Psychiatr Scand. 1990;82:77–81.

    Article  PubMed  CAS  Google Scholar 

  27. McHorney CA, Ware JE Jr, Lu JF, Sherbourne CD. The MOS 36-item short-form health survey (SF-36): III. Tests of data quality, scaling assumptions, and reliability across diverse patient groups. Med Care. 1994;32:40–66.

    Article  PubMed  CAS  Google Scholar 

  28. McHorney CA, Ware JE Jr, Raczek AE. The MOS 36-item short-form health survey (SF-36): II. Psychometric and clinical tests of validity in measuring physical and mental health constructs. Med Care. 1993;31:247–63.

    Article  PubMed  CAS  Google Scholar 

  29. Ware JE Jr, Sherbourne CD. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care. 1992;30:473–83.

    Article  PubMed  Google Scholar 

  30. Fraser CG. Biological variation: from principles to practice. Washington, DC: AACC Press; 2001.

    Google Scholar 

  31. van der Meer RW, Rijzewijk LJ, de Jong HW, Lamb HJ, Lubberink M, Romijn JA, Bax JJ, de RA, Kamp O, Paulus WJ, Heine RJ, Lammertsma AA, Smit JW, Diamant M: Pioglitazone improves cardiac function and alters myocardial substrate metabolism without affecting cardiac triglyceride accumulation and high-energy phosphate metabolism in patients with well-controlled type 2 diabetes mellitus. Circulation 2009;119:2069–77.

    Google Scholar 

  32. Livesey G, Elia M. Estimation of energy expenditure, net carbohydrate utilization, and net fat oxidation and synthesis by indirect calorimetry: evaluation of errors with special reference to the detailed composition of fuels. Am J Clin Nutr. 1988;47:608–28.

    PubMed  CAS  Google Scholar 

  33. Schousboe JT, Wilson KE, Hangartner TN. Detection of aortic calcification during vertebral fracture assessment (VFA) compared to digital radiography. PLoS ONE. 2007;. doi:10.1371/journal.pone.0000715.

    PubMed  Google Scholar 

  34. Brage S, Brage N, Franks PW, Ekelund U, Wong MY, Andersen LB, Froberg K, Wareham NJ. Branched equation modeling of simultaneous accelerometry and heart rate monitoring improves estimate of directly measured physical activity energy expenditure. J Appl Physiol. 2004;96:343–51.

    Article  PubMed  Google Scholar 

  35. Brage S, Brage N, Franks PW, Ekelund U, Wareham NJ. Reliability and validity of the combined heart rate and movement sensor Actiheart. Eur J Clin Nutr. 2005;59:561–70.

    Article  PubMed  CAS  Google Scholar 

  36. Heart rate variability: standards of measurement, physiological interpretation and clinical use. Task force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology. Circulation 1996;93:1043–65.

    Google Scholar 

  37. Chae KY, Kripke DF, Poceta JS, Shadan F, Jamil SM, Cronin JW, Kline LE. Evaluation of immobility time for sleep latency in actigraphy. Sleep Med. 2009;10:621–5.

    Article  PubMed  Google Scholar 

  38. WHO Collaboration Centre for Drug Statistics Methodology. Anatomical Therapeutic Chemical classification system. http://www.whocc.no/atc/ (2012). Accessed 1 Nov 2012.

  39. Wonca International Classification Committee. The international classification of primary care. http://www.ph3c.org/4daction/w3_CatVisu/en/icpc.html?wCatIDAdmin=1106 (2012). Accessed 1 Nov 2012.

  40. Vaartjes I, van Dis I, Visseren FLJ, Bots ML. Incidentie en prevalentie van hart- en vaatziekten in Nederland. In: Vaartjes I, van Dis I, Visseren FLJ, Bots ML, editors. Hart- en vaatziekten in Nederland 2010, cijfers over leefstijl- en risicofactoren, ziekte en sterfte. Den Haag: Nederlandse Hartstichting; 2010. p. 29–52.

    Google Scholar 

  41. Kolominsky-Rabas PL, Weber M, Gefeller O, Neundoerfer B, Heuschmann PU. Epidemiology of ischemic stroke subtypes according to TOAST criteria: incidence, recurrence, and long-term survival in ischemic stroke subtypes: a population-based study. Stroke. 2001;32:2735–40.

    Article  PubMed  CAS  Google Scholar 

  42. Fowkes FG. Epidemiological research on peripheral vascular disease. J Clin Epidemiol. 2001;54:863–8.

    Article  PubMed  CAS  Google Scholar 

  43. Felson DT, Zhang Y, Hannan MT, Naimark A, Weissman B, Aliabadi P, Levy D. Risk factors for incident radiographic knee osteoarthritis in the elderly: the Framingham Study. Arthritis Rheum. 1997;40:728–33.

    Article  PubMed  CAS  Google Scholar 

  44. Murphy JM, Olivier DC, Monson RR, Sobol AM, Leighton AH. Incidence of depression and anxiety: the Stirling County Study. Am J Public Health. 1988;78:534–40.

    Article  PubMed  CAS  Google Scholar 

  45. Yusuf S, Hawken S, Ounpuu S, Bautista L, Franzosi MG, Commerford P, Lang CC, Rumboldt Z, Onen CL, Lisheng L, Tanomsup S, Wangai P Jr, Razak F, Sharma AM, Anand SS. Obesity and the risk of myocardial infarction in 27,000 participants from 52 countries: a case-control study. Lancet. 2005;366:1640–9.

    Article  PubMed  Google Scholar 

  46. Hu G, Tuomilehto J, Silventoinen K, Sarti C, Mannisto S, Jousilahti P. Body mass index, waist circumference, and waist-hip ratio on the risk of total and type-specific stroke. Arch Intern Med. 2007;167:1420–7.

    Article  PubMed  Google Scholar 

  47. Nystad W, Meyer HE, Nafstad P, Tverdal A, Engeland A. Body mass index in relation to adult asthma among 135,000 Norwegian men and women. Am J Epidemiol. 2004;160:969–76.

    Article  PubMed  Google Scholar 

  48. Meisinger C, Doring A, Thorand B, Heier M, Lowel H. Body fat distribution and risk of type 2 diabetes in the general population: are there differences between men and women? The MONICA/KORA Augsburg cohort study. Am J Clin Nutr. 2006;84:483–9.

    PubMed  CAS  Google Scholar 

  49. http://www.nationaalkompas.nl/gezondheid-en-ziekte/ziekten-en-aandoeningen/endocriene-voedings-en-stofwisselingsziekten-en-immuniteitsstoornissen/diabetes-mellitus/prevalentie-en-incidentie-naar-leeftijd-en-geslacht. Accessed 20 March 2013

  50. Donders AR, van der Heijden GJ, Stijnen T, Moons KG. Review: a gentle introduction to imputation of missing values. J Clin Epidemiol. 2006;59:1087–91.

    Article  PubMed  Google Scholar 

  51. Shoukri MM, Asyali MH, Donner A. Sample size requirements for the design of reliability study: review and new results. Stat Methods Med Res. 2004;13:251–71.

    Google Scholar 

Download references

Acknowledgments

The NEO study is supported by the participating Departments, the Division and the Board of Directors of the Leiden University Medical Centre, and by the Leiden University, Research Profile Area ‘Vascular and Regenerative Medicine’. We express our gratitude to all individuals who participate in the Netherlands Epidemiology in Obesity study. We are grateful to all participating general practitioners for inviting eligible participants. We furthermore thank M.W.M. de Waal, PhD and H.J. de Jong, MSc of the Leiden Eerstelijns Onderzoeks Netwerk for their assistance with the recruitment. We greatly acknowledge P.R. van Beelen and research nurses: E. Baak; N. Besling; M.L. Bruijning; M.M. Bussink; A.M. van Diemen; C. van Dijk; K.K.M. Glas; C.H. van Houwelingen; M. van Houwelingen; L.A.M. Janssen; K.B.A. de Koning; S. van Luijken; D. Malsen; S.A. Meertens; W.M. Ninaber-de Jong; M. Ottenhof; S.J. Randelia; J. van Rewijk; V.C.E. van der Slot; J. Terpstra-Bevelander; I. Verhoogt; B. Vink; J.P. de Vreugd; E.C. Willems of Brilman for collecting the data, P.J. Noordijk; A.G.F Reymer; B.E.P.B. Ballieux; J.C.M. Verhagen for laboratory procedures and management, and R.J. van den Berg; M.W.J. Bergman; N. Brak; R. van Eck, BSc; L. Gullerud-Edberg; E.J. Hoenderdos; L. Mahic; J. van Rewijk; E.C. Sierat-van der Steen; A.K. Smeding, BSc; C.E. van der Velden-Krijgsman, MSc; C.H.E. de Vries-van Lingen; X. Yang for sample handling. We thank J. van Amersfoort; J. Bijsterbosch, MD; P. Dibbets-Schneider; M. van Dijk; J.M. Gast-Strookman; E. Ghariq; M.S. den Heyer-de Zoete; B. van der Hiel, MD; M.E. Janson; R.C. de Jeu; W.Y. Kwok, A.C. van der Linden; G.J.K. Linthorst-Pikkaart; M. Loef; M. Los; A.C. Maan; S. Ramanand; B.A.M.J. van Schie-Geyer; J.E.H. Schoumans-Mens; R. Schot; R.G.M. van Steijn; MD; R. Suttorius; D.H. Versteeg; A.O. Westerlaken for their help in data collection. We thank O.M. Dekkers, MD, PhD; L.J.M. Kroft, MD; M. Reijnierse, MD for medical assistance. The fellows A.W. de Boer, MD; E. Donga, MD; K.B. Gast, MD; S. Hillebrand, MSc; W.T. Thijs, MD; A.W. Visser, MSc; R.L. Widya, MD; E. Yusuf, MD took part in the data collection. We sincerely thank I. de Jonge, MSc for all data management of the NEO study. We thank Danone Research Centre for Specialised Nutrition B.V., Wageningen, for providing the mixed meal.

Conflict of interest

The authors declare that they have no conflict of interest.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Renée de Mutsert.

Additional information

This study was conducted for the NEO Study Group.

Please refer the “Appendix” section for NEO Study Group members.

Appendix

Appendix

NEO Study Group

Frits R. Rosendaal, Renée de Mutsert, Saskia Middeldorp, Ton J. Rabelink, Johannes W.A. Smit, Johannes A. Romijn, Klaus F. Rabe, J. Wouter Jukema, Albert de Roos, Saskia le Cessie, Pieter S. Hiemstra, Margreet Kloppenburg, Ton W.J. Huizinga, Hanno Pijl, Jouke T. Tamsma, Eelco J.P. de Koning, Pim J.J. Assendelft, Pieter H. Reitsma, Ko Willems van Dijk, Aiko P.J. de Vries, Hildo J. Lamb, Ingrid M. Jazet, Olaf M. Dekkers, Nienke R. Biermasz, Christa M. Cobbaert (Leiden University and Medical Center, Leiden, the Netherlands), Martin den Heijer, Jacqueline M. Dekker and Brenda W. Penninx (VU Medical Center, Amsterdam, The Netherlands).

Rights and permissions

Reprints and permissions

About this article

Cite this article

de Mutsert, R., den Heijer, M., Rabelink, T.J. et al. The Netherlands Epidemiology of Obesity (NEO) study: study design and data collection. Eur J Epidemiol 28, 513–523 (2013). https://doi.org/10.1007/s10654-013-9801-3

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10654-013-9801-3

Keywords

Navigation